JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies

od Jatiani, Shashidhar S., Baker, Stacey J., Silverman, Lewis R., Reddy, E. Premkumar
Izdano 2010

Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra

od Jatiani, Shashidhar S., Aleman, Adolfo, Madduri, Deepu, Chari, Ajai, Cho, Hearn Jay, Richard, Shambavi, Richter, Joshua, Brody, Joshua, Jagannath, Sundar, Parekh, Samir
izdano v Clin Lymphoma Myeloma Leuk (2020)

SOX11 augments BCR signaling to drive MCL-like tumor development

od Kuo, Pei-Yu, Jatiani, Shashidhar S., Rahman, Adeeb H., Edwards, Donna, Jiang, Zewei, Ahr, Katya, Perumal, Deepak, Leshchenko, Violetta V., Brody, Joshua, Shaknovich, Rita, Ye, B. Hilda, Parekh, Samir
izdano v Blood (2018)

A Non–ATP-Competitive Dual Inhibitor of JAK2(V617F) and BCR-ABL(T315I) Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition

od Jatiani, Shashidhar S., Cosenza, Stephen C., Reddy, M.V. Ramana, Ha, Ji Hee, Baker, Stacey J., Samanta, Ajoy K., Olnes, Matthew J., Pfannes, Loretta, Sloand, Elaine M., Arlinghaus, Ralph B., Reddy, E. Premkumar
Izdano 2010

Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)

od Reddy, M. V. Ramana, Akula, Balireddy, Jatiani, Shashidhar, Vasquez-Del Carpio, Rodrigo, Billa, Vinay K., Mallireddigari, Muralidhar R., Cosenza, Stephen C., Subbaiah, D. R. C. Venkata, Bharathi, E. Vijaya, Pallela, Venkat R., Ramkumar, Poornima, Jain, Rinku, Aggarwal, Aneel K., Reddy, E. Premkumar
izdano v Bioorg Med Chem (2015)